1
Return

Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium

delete2026-06-22
delete0
PRE
AI
I
Ivan Foeldvari *
K
Kathryn S. Torok *
J
Jens Klotsche
J
Jonathan C. Li
C
Cosimo Bruni
P
Patricia Costa-Reis
M
Maurizio Cutolo
C
Christopher P. Denton
K
Kim Fligelstone
F
Francesco Del Galdo
C
Clara Giménez-Roca
J
Jörg Henes
O
Ozgur Kasapcopur
S
Suzanne C. Li
E
Edoardo Marrani
C
Catherine H. Orteu
J
John D. Pauling
C
Clarissa Pilkington
L
Laura Ross
D
Dieneke Schonenberg-Meinema
D
Daniel E. Furst
V
Vanessa Smith
DOI:10.1080/1744666X.2026.2685050delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Assessment of disease activity in juvenile systemic sclerosis (jSSc) is essential for clinical care and trial readiness, yet no validated pediatric activity measures exist. Adult systemic sclerosis activity tools, including the Scleroderma Clinical Trials Consortium Activity Index, revised CRISS, and revised EUSTAR, provide conceptual frameworks but require adaptation for developmental, physiologic, and feasibility considerations for children. At the 17th Hamburg Symposium on JSSc, an international multidisciplinary panel reviewed adult indices, evaluated corresponding variables in the jSSc Inception Cohort and the NRCOS registry, and conducted a structured Delphi process to define organ-specific indicators of clinically meaningful activity in jSSc. Across skin, pulmonary, cardiac, vascular, musculoskeletal, gastrointestinal, renal, and global domains, the panel reached broad and often unanimous consensus on variables reflecting active, potentially reversible disease. Key endorsed measures included mRSS progression, new ILD on HRCT, ≥10% declines in FVC or DLCO, new cardiac abnormalities, active digital ulcers, synovitis, myositis, nutritional decline, and physician global assessment. Patient-reported outcomes were strongly supported across domains. These consensus-derived indicators provide the first comprehensive pediatric-specific foundation for defining disease activity in jSSc and represent a critical step toward developing and validating a unified pediatric activity index suitable for future clinical trials.
Keywords:
Clinical trials
consensus
disease activity
disease activity index
juvenile systemic sclerosis
pediatric rheumatology
outcome measures

Journal

Expert Review of Clinical Immunology cover
Expert Review of Clinical Immunology
IF:
3.7
Papers:
2.1K
Citations:
4.6K

Organization

F
fesca
Scholars:
2
Papers: 2
Citations: 0
S
Schön Klinik Hamburg Eilbek
Scholars:
3
Papers: 1.1K
Citations: 118
N
North Bristol NHS Trust
Scholars:
1.9K
Papers: 1.3K
Citations: 1.3K
H
Hackensack Meridian School of Medicine
Scholars:
94
Papers: 48
Citations: 0
I
istanbul university - cerrahpaşa
Scholars:
303
Papers: 134
Citations: 0
A
Amsterdam University Medical Centers
Scholars:
402
Papers: 193
Citations: 2.9W
U
university of zurich
Scholars:
4.9W
Papers: 3.9W
Citations: 65
G
ghent university
Scholars:
3.8K
Papers: 1.5K
Citations: 0
G
german rheumatism research center
Scholars:
4
Papers: 4
Citations: 0
G
Great Ormond Street Hospital
Scholars:
145
Papers: 68
Citations: 7.0K
U
University Hospital Tubingen
Scholars:
91
Papers: 32
Citations: 0
U
Universidade de Lisboa
Scholars:
2.7K
Papers: 1.2K
Citations: 1
U
University of California
Scholars:
7.3K
Papers: 2.8K
Citations: 8.3W
M
meyer children’s hospital irccs
Scholars:
74
Papers: 32
Citations: 0
Royal Free London NHS Foundation Trust cover
Royal Free London NHS Foundation Trust
Scholars:
94
Papers: 64
Citations: 1.8K
H
hospital sant joan de déu
Scholars:
262
Papers: 104
Citations: 0
U
university of melbourne
Scholars:
5.6W
Papers: 5.4W
Citations: 69
U
university of pittsburgh
Scholars:
5.1K
Papers: 2.3K
Citations: 1
Cited Papers

Cited Papers

Citing Papers

Citing Papers